483 Cubist Pharmaceuticals Jul 2014

483 Cubist Pharmaceuticals Jul 2014

Stacey Degarmo FDA, Ramon Martinez FDA, Mary-Jeanet Mcgarry FDA$119.00 - Available Now

FDA investigators audited the Cubist Pharmaceuticals - Lexington, MA, United States facility and issued inspectional observations (via FDA 483) on 10 Jul 2014.

Product details

  • Category: Human Drugs
  • Inspection end: 10 Jul 2014
  • Location: Lexington, United States
  • FEI: 1000513172
Add To Cart